RxDoctor Payments Data

James Barnes, MD

Family Medicine · Columbus, OHNPI 1235177007

Payments from drug & device makers

$4,704in general payments, 2019–2025

Across 321 payments — averaging $14.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$926
  • AbbVie$477
  • AstraZeneca$413
  • Pfizer$374
  • GSK$273
  • Lilly USA, LLC$258
  • plus $2K from 43 others

What the payments were for

  • Food & beverage$4,704100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,704 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$96,730
Medicare patients
264
Services billed
983

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban121$144,141
OzempicSemaglutide54$93,627
MounjaroTirzepatide47$60,709
XareltoRivaroxaban38$40,707
TrulicityDulaglutide20$33,077
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$29,997
JardianceEmpagliflozin25$28,486
JanuviaSitagliptin Phosphate16$22,080
ProliaDenosumab11$18,655
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$17,142
FarxigaDapagliflozin Propanediol19$16,047
Tresiba Flextouch U-100Insulin Degludec11$15,892
Tresiba Flextouch U-200Insulin Degludec11$11,802
DuleraMometasone/Formoterol23$11,799
Atorvastatin Calcium563$6,853

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$374$144,141121 claims
Lilly USA, LLCMounjaro, Trulicity$258$93,78667 claims
Novo NordiskOzempic$926$93,62754 claims
Johnson & JohnsonXarelto$40$40,70738 claims
MerckJanuvia, Dulera$116$33,87939 claims
GSKTrelegy Ellipta$273$29,99731 claims
Boehringer IngelheimJardiance$14$28,48625 claims
AmgenProlia$123$18,65511 claims
AstraZenecaFarxiga$413$16,04719 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$2,428269 claims
AbbVieSynthroid$477$1,53142 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →